This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul m Replaced skeletal structure image with standardised svg image. |
>Kenan m fix broken data |
||
| Line 57: | Line 57: | ||
|OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | |OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy=[[Oral min | |OralROA_Heavy=[[Oral min heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
| Line 74: | Line 74: | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | ||
|InsufflatedROA_Heavy=[[Insufflated min | |InsufflatedROA_Heavy=[[Insufflated min heavy dose::20]] mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
| Line 81: | Line 81: | ||
|InsufflatedROA_Peak= | |InsufflatedROA_Peak= | ||
|InsufflatedROA_Offset= | |InsufflatedROA_Offset= | ||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max | |InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max afterglow time::12]] [[Insufflated afterglow time units::hours]] | ||
}} | }} | ||
Revision as of 13:43, 21 December 2017
| SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||
| Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||
| Systematic name | 2-(Ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
| Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||